장기칩(Organs-on-Chips) 시장 : 업계 동향과 세계 예측(-2035년) - 제품 유형별, 장기 유형별, 단일 장기 기반 모델별, 구성 재료별, 목적별, 응용 분야별, 최종사용자별, 주요 지역별
Organs-on-Chips Market: Industry Trends and Global Forecasts, Till 2035 Distribution by Product, Organ, Single Organ based Model, Material of Construction, Purpose, Application Area, End User, Key Geographical Regions and Leading Players
상품코드:1869577
리서치사:Roots Analysis
발행일:2025년 11월
페이지 정보:영문 218 Pages
라이선스 & 가격 (부가세 별도)
한글목차
장기칩 시장 : 개요
Roots Analysis의 조사에 따르면, 세계 장기칩(Organ-on-chip) 시장 규모는 현재 1억 달러에서 2035년까지 9억 4,400만 달러로 성장할 것으로 예측됩니다. 예측 기간(2035년까지)의 CAGR은 25.2%로 예상됩니다.
장기칩 시장의 기회는 다음과 같은 부문에 분산되어 있습니다.
제품 유형
장기 베이스
질병 기반
장기 유형
단일 장기 기반
다장기 기반
단일 장기 기반 모델
간
폐
두뇌
심장
장
신장
기타
구조 재료
폴리디메틸실록산
기타 폴리머
유리
기타
용도
조사
치료
응용 분야
신약 개발 및 독성 시험
암 연구
줄기세포 연구
조직공학 및 재생의료
기타
최종 사용자
제약 및 바이오 기업
학술 및 연구기관
화장품 업계 관계자
기타
주요 지역
북미
유럽
아시아태평양
라틴아메리카
중동 및 북아프리카
주요 기업
장기칩 시장 : 성장과 동향
조사에 따르면, 1,000개의 의약품 후보물질 중 전임상 평가를 거쳐 임상시험에 진입하는 것은 단 1개에 불과합니다. 이 중 90%의 후보물질은 주로 임상시험에서 확인된 유효성 부족이나 예상치 못한 독성, 복잡한 인체 생물학적 특성 및 기전을 재현하는 문제, 동물 기반 전임상 모델로는 인체 반응을 정확하게 예측할 수 없습니다는 한계로 인해 시장 출시에 이르지 못하고 있는 실정입니다. 따라서 이러한 문제점과 한계를 극복하고 약물 실패로 인한 의료 부담을 줄이기 위해 많은 연구자들이 장기칩 기술 등 대체 시험 방법의 도입을 위해 노력하고 있습니다. 또한, 혁신신약과 맞춤의료의 발견을 가속화하기 위해서는 인간의 생물학 및 병태를 보다 정밀하게 체외에서 재현하는 기술이 요구되고 있습니다. 장기칩(Organs-on-a-chip)은 미세생리시스템(MPS)이라고도 불리며, 살아있는 세포를 수용한 체외 마이크로플루이딕스 장치로 인간의 생리적 기능을 모방하여 세포의 미세환경과 질병의 병태생리를 상세하게 묘사합니다. 이 칩은 미세 가공 기술을 사용하여 재구축된 칩으로, 살아있는 세포(세포 배양 배지가 지속적으로 관류되는)가 들어있는 챔버를 갖추고 있어 인체 조직의 물리 화학적 미세 환경을 모방합니다.
현재 시장에는 75종의 통합형 장기칩 기술 및 모델이 존재하며, 기존 세포배양법이나 동물실험에 비해 인간과 유사한 생리적 반응 예측 정확도, 높은 생체 내 재현성, 시험비용 절감, 동물모델 의존도 감소 등 뚜렷한 우위를 가지고 있습니다.
동물대체시험에 대한 수요 증가, 관련 법규의 정비, 투자 및 제휴 활동의 활성화, 마이크로플루이딕스 기술의 발전으로 장기칩 시장은 지난 몇 년 동안 꾸준한 성장세를 보이고 있습니다. 그러나 시장 성장에는 몇 가지 억제요인이 존재할 수 있습니다. 구체적으로는 장기칩이 전임상시험에 국한된 점, 확립된 프로토콜과 표준화의 부족, 장기-만성 연구에서의 적용 범위의 협소함 등을 들 수 있습니다. 또한, 최적의 구조 재료의 선택, 다장기 통합의 복잡성, 효과 향상을 위한 보조 장치 통합의 영향 등의 문제도 시장에서 발생할 수 있습니다. 따라서 위의 과제를 극복하기 위해서는 장기칩 제공업체들이 협력하여 제조 공정의 표준화를 위해 노력해야 합니다.
시장의 성장/쇠퇴는 여러 요인이 복합적으로 작용합니다. 따라서 업계 내 리스크/과제를 평가하고, 이를 극복하기 위한 접근 방식을 모니터링하고, 기회를 활용하는 것은 기업이 이 분야에서 사업을 확장하는 데 도움이 될 수 있습니다. 또한, 장기칩 분야의 지속적인 혁신과 투자, 그리고 새로운 기술의 채택 확대를 고려할 때, 시장은 앞으로 크게 성장할 것으로 예측됩니다.
장기칩 시장 : 주요 인사이트
이 보고서는 장기칩 시장의 현황을 상세하게 분석하고 업계 내 잠재적인 성장 기회를 식별합니다. 주요 조사 결과는 다음과 같습니다.
70여 가지 이상의 장기칩 기술 및 모델이 이미 출시 및 승인되었거나 현재 개발 중입니다. 시장 상황에는 기존 기업과 신규 진출기업 모두 존재합니다.
대부분의 기술 및 모델은 장기 기반 및 질병 기반 응용 분야 모두에 적용 가능합니다. 그 중 98%의 기술/모델이 신약개발 및 독성시험 연구에 우선적으로 채택되고 있습니다.
현재 25개 기업(기존 기업 및 신생 기업)이 장기칩과 플레이트를 제공한다고 주장하고 있습니다. 이들 기업의 60% 이상이 2013년 이후 설립된 기업입니다.
장기칩 제품의 50% 이상이 마이크로플루이딕스 플레이트이며, 흥미롭게도 이러한 칩과 플레이트의 대부분은 유연성과 성형성 때문에 폴리머로 구성되어 있습니다.
산업계 및 비산업계 이해관계자들에 의해 600건 이상의 장기칩 관련 특허가 출원 및 승인되어 이 분야의 지적 자본의 성장을 보여주고 있습니다.
이해관계자들의 관심이 높아진 것은 파트너십 활동 증가에서도 알 수 있습니다. 기술 및 제품 사용 계약은 장기칩 제공업체가 채택하는 가장 일반적인 파트너십 모델로 부상하고 있습니다.
장기칩 제품 및 기술에 대한 지속적인 연구 개발 활동에 대해 약 350건의 보조금이 수여되었습니다. 국립번역과학진흥센터가 가장 많은 지원금을 수여하고 있습니다.
2017년 이후 여러 투자자들이 다양한 펀딩 라운드에서 3억 5,000만 달러 이상을 투자하여 이 신흥 분야에서 수익성 높은 성장 기회를 제공합니다.
최근 이해관계자들은 장기칩에 대한 수요 증가에 대응하기 위해 강력한 브랜드 포지셔닝을 구축했습니다. 여러 기업이 효율적이고 사용하기 쉬운 첨단 제품을 도입하고 있습니다.
비동물 실험에 대한 수요 증가와 마이크로플루이딕스 기술의 발전은 장기칩 시장의 급속한 발전을 뒷받침하는 주요 촉진요인으로 부상하고 있습니다.
장기칩이 동물을 사용하지 않는 시험 모델을 제공하고, 약물 시험과 관련된 비용을 크게 절감할 수 있기 때문에 향후 10년간 25.2% 시장 성장이 예상됩니다.
장기칩 시장 : 주요 부문
제품 유형별로 세계 장기칩 시장은 장기 기반 모델과 질병 기반 모델로 구분됩니다. 현재 장기칩 시장의 대부분은 장기 기반 모델이 차지하고 있습니다. 특히 질병 기반 모델 부문은 향후 몇 년 동안 더 높은 CAGR(약 27%)로 성장할 가능성이 높다는 점을 주목할 필요가 있습니다.
장기 유형별로 세계 장기칩 시장은 단일 장기 모델과 다중 장기 모델로 분류됩니다. 단일 장기 모델을 지원하는 장기칩 제품이 시장 점유율의 대부분을 차지하고 있지만, 예측 기간 동안 다장기 모델용 장기칩 시장이 상대적으로 높은 CAGR로 성장할 것으로 예상된다는 점은 주목할 만합니다. 이는 다장기 모델이 대사 경로를 효율적으로 추적할 수 있는 능력에 기인합니다.
단일 장기 기반 모델별로 세계 시장은 간, 폐, 뇌, 심장, 심장, 장, 신장, 기타 장기 기반 모델로 구분됩니다. 현재 간 온칩 모델이 시장을 장악하고 있으며, 전체 성장을 주도할 것으로 예측됩니다. 예측 기간 동안 폐, 뇌, 심장 온칩 모델이 성장할 가능성이 높다는 점도 주목할 만합니다. 이는 이러한 모델들이 인간의 생물학적 메커니즘을 정확하고 복잡하게 모방할 수 있는 능력에 기인하는 것으로 보입니다.
재료 유형별로 세계 시장 규모는 폴리디메틸실록산(PDMS), 기타 폴리머, 유리, 기타 재료로 분류됩니다. 특히 PDMS의 높은 유연성, 투명성, 가스 투과성으로 인해 예측 기간 동안 장기칩 시장을 독점할 가능성이 높을 것으로 보입니다.
치료 목적의 장기칩 시장은 예측 기간 동안 높은 CAGR로 성장할 것으로 예측됩니다.
용도별로 세계 시장은 조사 목적과 치료 목적으로 구분됩니다. 현재 조사 목적에 중점을 둔 장기칩이 전체 시장에서 큰 비중을 차지하고 있습니다. 그러나 여러 치료 영역에서 해당 칩의 적용이 확대됨에 따라 이러한 추세는 예측 기간 동안 변화할 가능성이 높을 것으로 보입니다.
응용 분야별로 살펴보면, 전 세계 장기칩 시장은 신약개발 및 독성시험, 암 연구, 줄기세포 연구 및 조직공학, 재생의료로 분산되어 있습니다. 암 연구용 장기칩 모델 및 플레이트가 전체 시장을 주도하는 한편, 줄기세포 연구 및 조직공학에 사용되는 장기칩 모델 시장이 상대적으로 높은 CAGR로 성장할 가능성이 높다는 점은 주목할 만합니다.
최종 사용자별로 보면, 세계 시장은 제약 및 바이오테크놀러지 기업, 학술 및 연구기관, 화장품 산업, 기타 최종 사용자로 구분됩니다. 현재 제약 및 생명공학 기업이 가장 큰 시장 점유율을 차지하고 있습니다. 그러나 화장품 산업을 위한 장기칩 시장은 향후 몇 년 동안 큰 폭의 성장이 예상됩니다.
주요 지역별로 시장은 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 북아프리카로 구분됩니다. 현재로서는 북미가 가장 큰 시장 점유율을 차지할 것으로 예측됩니다. 그러나 유럽 국가들의 동물실험 금지로 인해 유럽 장기칩 시장은 예측 기간 동안 높은 CAGR로 성장할 것으로 예측됩니다.
장기칩 시장의 대표 기업들
4DCell
Aim biotech
Beonchip
Bi/ond
CN BIO
Emulate
InSphero
Jiksak Bioengineering
Kirkstall
Lena Biosciences
Merck Millipore
MesoBio Tech
MicroBrain Biotech
Mimetas
Numa Biosciences
Qureator
SynVivo
TissUse
Visikol
Xona microfluidics
목차
제1장 서문
제2장 조사 방법
제3장 시장 역학
제4장 경제적 및 기타 프로젝트 특유의 고려사항
제5장 주요 요약
제6장 서론
본 장의 개요
장기칩 역사적 진화
장기칩 설계
장기칩 분류
장기칩 이점과 한계
장기칩 응용
향후 전망
제7장 시장 구도 : 장기칩 기술과 모델
본 장의 개요
장기칩 기술 및 모델 시장 : 시장 구도
장기칩 기술과 모델 시장 : 개발자 상황
제8장 시장 구도 : 칩 및 플레이트상 장기
제9장 장기칩 프로바이더 : 북미에 거점을 둔 기업 개요
본 장의 개요
Emulate
SynVivo
Draper
Hesperos
Xona Microfluidics
제10장 장기칩 프로바이더 : 유럽에 거점을 둔 기업 개요
본 장의 개요
CN Bio
Dynamic42
InSphero
Beonchip
BiomimX
Mimetas
NETRI
React4life
TissUse
제11장 장기칩 프로바이더 : 아시아태평양에 거점을 둔 기업 개요
본 장의 개요
Aim biotech
제12장 특허 분석
제13장 브랜드 포지셔닝 분석 : 장기칩 기술과 모델 프로바이더
제14장 브랜드 포지셔닝 분석 : 장기칩 및 플레이트 프로바이더
본 장의 개요
조사 방법
주요 파라미터
장기칩 및 플레이트 프로바이더 : 브랜드 포지셔닝 프레임워크
제15장 학술 보조금 분석
본 장의 개요
범위와 조사 방법
장기칩 : 학술 보조금 분석
제16장 파트너십 및 협업
제17장 자금조달과 투자 분석
제18장 사례 연구 : 스캐폴드 프리 3D 세포배양 시스템
제19장 시장 영향 분석 : 성장 촉진요인 및 억제요인, 기회, 과제
본 장의 개요
시장 성장 촉진요인
시장 성장 억제요인
시장 기회
시장이 해결해야 할 과제
결론
제20장 세계의 장기칩 시장
제21장 장기칩 시장(제품 유형별)
제22장 장기칩 시장(장기 유형별)
제23장 장기칩 시장(단일 장기 기반 모델별)
제24장 장기칩 시장(구성 재료별)
제25장 장기칩 시장(목적별)
제26장 장기칩 시장(응용 분야별)
제27장 장기칩 시장(최종사용자별)
제28장 장기칩 시장(지역별)
제29장 결론
제30장 경영진 인사이트
제31장 부록 1 : 표 형식 데이터
제32장 부록 2 : 기업 및 단체 리스트
LSH
영문 목차
영문목차
Organs-on-Chips Market: Overview
As per Roots Analysis, the global organ-on-chip market size is estimated to grow from USD 100 million in the current year to USD 944 million by 2035, at a CAGR of 25.2% during the forecast period, till 2035.
The opportunity for organ on a chip market has been distributed across the following segments:
Type of Product
Organ based
Disease based
Type of Organ
Single organ based
Multi organ based
Type of Single Organ based Model
Liver
Lung
Brain
Heart
Intestine
Kidney
Other organs
Type of Material of Construction
Polydimethylsiloxane
Other polymer
Glass
Others
Purpose
Research
Therapeutic
Application Area
Drug discovery / toxicity testing
Cancer research
Stem cell research
Tissue engineering / regenerative medicine
Others
End User
Pharmaceutical and biotech companies
Academic and research players
Cosmetic industry players
Other end users
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Leading Players
Organs-on-Chips Market: Growth and Trends
Research suggests that 1 in every 1,000 drug candidates advance to clinical trials after preclinical evaluation. Among these, 90% of the candidates fail to enter the market, primarily because of insufficient efficacy or unexpected toxicity observed during clinical trials, as well as the limitations of animal-based preclinical models to accurately anticipate human reactions (due to challenges in replicating the complex human biology and mechanisms). Therefore, to address these issues / limitations and in an effort to reduce the healthcare burden due to drug failures, several researchers are striving to adopt alternative testing methods, such as organ-on-a-chip technology. Further, in order to fasten the discovery of innovative drugs and personalized medication, improved in vitro simulation of human biology and pathologies is required. Organs-on-a-chip, also known as micro-physiological systems (MPS), are in vitro microfluidic devices, housing living cells that imitate human physiology, thereby providing detailed descriptions of the cell microenvironment and disease pathophysiology. These chips are remodeled using microfabrication techniques and have chambers with live cells (continually perfused with cell culture media) that mimic the physio-chemical microenvironment of tissues in the human body.
At present, 75 integrated organ-on-chip technologies and models are available in the market, offering distinct advantages over the traditional cell culture and animal-based testing methods, such as enhanced accuracy in predicting physiological responses like humans, high in vivo replicability, reduced trial costs and dependency on animal models.
Owing to the increased demand for animal free testing, emergence of laws and increased investment and partnership activity, coupled with the advancements in microfluidics, the organ-on-chip market has witnessed steady growth over the past few years. However, the market's growth may be hindered by certain factors, such as the limitation of organ-on-chips to preclinical trials, lack of established protocols and standardization, and the limited use of organ-on-chips in long-term and chronic studies. In addition, the organ-on-chip market may face some challenges due to the choice of ideal material of construction, complexity of multi-organ integration and impact of integrating ancillary devices for enhanced efficacy. Therefore, in order to overcome the abovementioned challenges, organ-on-chip providers are required to collectively work towards the standardization of organ-on-chip manufacturing process.
Multiple factors are collectively responsible for the growth / decline of a market. Therefore, assessing the risks / challenges within an industry, monitoring approaches to overcome the challenges and capitalizing the opportunities, can help the companies to expand their business operations within this domain. Further, considering the continued innovation and investments in the organ-on-chip domain, along with increased adoption of new technologies, the market is anticipated to grow significantly in the coming future.
Organs-on-Chips Market: Key Insights
The report delves into the current state of the organs-on-chips market and identifies potential growth opportunities within the industry. Some key findings from the report include:
More than 70 organ-on-chip technologies and models have been launched / approved or are currently under development; the market landscape features the presence of both established players and new entrants.
Majority of the technologies and models support both organ-based and disease-based applications; of these, 98% of the technologies / models are preferred for drug discovery and toxicity testing studies.
Presently, 25 players (established players as well as start-ups) claim to provide organ-on-chips and plates; more than 60% of these firms have been established post-2013.
Over 50% of organ-on-chips products are microfluidic plates; interestingly, majority of these chips and plates are constructed from polymers due to their flexibility and moldability.
More than 600 patents related to organ-on-chip have been filed / granted by industry and non-industry stakeholders, indicating a growing intellectual capital in the domain.
The growing interest of stakeholders is evident from the increasing partnership activities; technology / product utilization agreements emerged as the most prevalent partnership model adopted by organ-on-chip providers.
Close to 350 grants have been awarded for ongoing research and development efforts for organ-on-chip products and technologies; National Center for Advancing Translational Sciences has awarded the maximum grant amount.
Since 2017, over USD 350 million have been invested by several investors across various funding rounds, thereby presenting lucrative growth opportunities within this emerging segment.
In recent years, stakeholders have established strong brand positions to cater to the increasing demand for organ-on-chips; several players have introduced efficient, easy to use, and advanced products.
The growing demand for animal free testing and advancements in microfluidics has emerged as key driving factors supporting the rapid evolution of the organ-on-chip market.
Owing to the ability of organ-on-chips to provide animal free testing models and substantially reduce the costs associated with drug testing, the market is anticipated to witness a growth of 25.2% over the next decade.
Organs-on-Chips Market: Key Segments
Disease-based Model is the Fastest Growing Segment of the Organs-on-Chips Market
Based on the type of product, the global market for organs-on-chips is segmented into organ based and disease-based models. Currently, majority share of the organ-on-chip market is captured by organ-based models. It is worth mentioning that the disease-based model segment is likely to grow at a higher CAGR (around 27%) in the coming years.
Organ-on-Chip Products Supporting Single Organ-based Models are Likely to Dominate the Organs-on-Chips Market During the Forecast Period
Based on the type of organ, the global organs-on-chips market is distributed across single organ and multi organ-based models. While the organs-on-chip products supporting single organ-based models hold the majority of the market share, it is worth noting that organ-on-chip market for multi-organ-based models is likely to grow at a relatively higher CAGR during the forecast period. This can be attributed to the capability of multi-organ models to efficiently track metabolic pathways.
Liver-on-a-Chip Models are Likely to Hold the Largest Share of the Organs-on-Chips Market During the Forecast Period
Based on the type of single organ-based model, the global market is segmented into liver, lung, brain, heart, intestine, kidney and other organs-based models. Currently, the liver-on-a-chip models are likely to dominate and drive the overall market growth. It is worth noting that the lung, brain, and heart-on-a-chip models are likely to flourish during the forecast period. This can be attributed to the ability of these models to mimic the exact and intricate human biology / mechanisms.
Organs-on-Chips Market for Other Polymers is Likely to Grow at a Relatively Faster Pace During the Forecast Period
Based on the type of material, the global market value is segmented across polydimethylsiloxane (PDMS), other polymers, glass and other materials. Notably, owing to the high flexibility, transparency and gas permeability of PDMS, it is likely to dominate the organs-on-chips market during the forecast period.
Organs-On-Chips Market for Therapeutic Purposes is Likely to Grow at a Higher CAGR During the Forecast Period
Based on purpose, the global market is segmented into research and therapeutic purposes. Currently, organ-on-chips focussed on research purposes hold a larger share of the overall market. However, this trend is likely to change during the forecast period due to the expanding application of such chips across multiple therapeutic areas.
By Application Area, Organs-on-Chips for Cancer Research are Likely to Dominate the Market During the Forecast Period
Based on the application area, the global market for organs on chips is distributed across drug discovery and toxicity testing, cancer research, stem cell research and tissue engineering and regenerative medicines. While the organs-on-chip models and plates for cancer research will be the primary drivers of the overall market, it is worth highlighting that the market for organ-on-chips models used in stem cell research and tissue engineering is likely to grow at a relatively higher CAGR.
Currently, Pharmaceutical and Biotech Companies Hold the Largest Share of the Organs-On-Chips Market
Based on end users, the global market is segmented into pharmaceutical and biotech companies, academic and research players, cosmetic industry players, and other end users. Currently, pharmaceutical and biotech companies hold the largest market share. However, organ-on-chip market for cosmetic industry is expected to witness substantial growth in the coming years.
North America Accounts for the Largest Share of the Market
Based on key geographical regions, the market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East and North Africa. In the current scenario, North America is likely to capture the largest market share. However, owing to the ban on animal model testing in European countries, the organ-on-chip market in Europe is expected to grow at a higher CAGR during the forecast period.
Example Players in the Organs-on-Chips Market
4DCell
Aim biotech
Beonchip
Bi/ond
CN BIO
Emulate
InSphero
Jiksak Bioengineering
Kirkstall
Lena Biosciences
Merck Millipore
MesoBio Tech
MicroBrain Biotech
Mimetas
Numa Biosciences
Qureator
SynVivo
TissUse
Visikol
Xona microfluidics
Primary Research Overview
The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders. The research report features detailed transcripts of interviews held with the following industry stakeholders:
Chief Executive Officer, Small Company, US
Chief Executive Officer, Mid-sized Company, France
Chief Executive Officer, Small Company, South Korea
Chief Executive Officer, Small Company, Italy
Chief Executive Officer, Small Company, Scotland
Chief Technology Officer, Mid-sized Company, The Netherlands
Chief Business Development Officer, Mid-sized Company, France
President, Mid-sized Company, US
Organs-on-Chips Market: Research Coverage
The report on Organs-on-Chips Market features insights on various sections, including:
Market Sizing and Opportunity Analysis: An in-depth analysis of the organ-on-chip market, focusing on key market segments, including [A] type of product, [B] type of organ, [C] type of single organ-based model, [D] type of material of construction, [E] purpose, [F] application area, [G] end user, [H] key geographical regions and [I] leading players.
Market Impact Analysis: A thorough analysis of various factors, such as drivers, restraints, opportunities, and existing challenges that are likely to impact market growth.
Organ-on-Chip Technologies and Models Market Landscape: A comprehensive evaluation of organ-on-chips and plates, based on several relevant parameters, such as [A] type of model, [B] compatible organ, and [C] application area.
Organ-on-Chip Technologies and Models Developer Landscape: The report features a list of players engaged in the development of organ-on-chips and plates offered, along with analyses based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading technology providers.
Organ-on-Chip and Plates Market Landscape: A comprehensive evaluation of organ-on-chips and plates, based on several relevant parameters, such as [A] type of product, [B] type of model, [C] compatible organs, [D] application area, [E] material of construction, [F] type of polymer and [G] status of development.
Organ-on-Chip and Plates Developer Landscape: The report features a list of players engaged in the development of organ-on-chips and plates offered, along with analyses based on [A] year of establishment, [B] company size, [C] location of headquarters and [D] leading chips and plate providers.
Company Profiles: In-depth profiles of key industry players offering big data analytics solutions across various geographies, focusing on [A] company overviews, [B] financial information (if available), [C] organ-on-chip portfolio, [D] recent developments and [E] an informed future outlook.
Patents Analysis: An in-depth analysis of patents filed / granted till date in the organ-on-chip domain, based on various relevant parameters, such as [A] type of patent, [B] publication year, [C] application year, [D] patent jurisdiction, [E] CPC symbols, [F] type of applicant, [G] patent age, [H] leading inventors, [I] leading industry and non-industry players, [J] patent benchmarking, and [K] patent valuation analysis.
Brand Positioning Analysis: A detailed analysis of the [A] organ-on-chip technology and model providers and [B] organ-on-chips and plate providers, highlighting the current perceptions regarding their proprietary technologies, models, chips and plates by taking into consideration several relevant aspects, such as portfolio strength, portfolio diversity, years of experience, and company size.
Academic Grants Analysis: A comprehensive assessment of grants that have been awarded to research institutes in the organ-on-chip domain, based on various relevant parameters, such as [A] year of award, [B] amount awarded, [C] administering institute center, [D] support period, [E] type of grant application, [F] purpose of grant, [G] activity code, [H] emerging focus area, [I] study section involved, [J] popular NIH departments, [K] type of recipient organization, [L] leading recipient organizations and [M] location of recipient organization.
Partnerships and Collaborations: An insightful analysis of the deals inked by stakeholders in organs-on-chips market, based on several parameters, such as [A] year of partnership, [B] type of partnership, [C] type of organ, [D] geographical regions, [E] purpose of partnership, [F] most active players and [G] geographical distribution of partnership activity.
Funding and Investment Analysis: An in-depth analysis of the fundings raised by organ-on-chip companies, based on relevant parameters, such as [A] year of funding, [B] type of funding, [C] amount invested (USD million), [D] purpose of funding, [E] associated organ / system, [F] therapeutic area, [G] geographical area, and [H] most active players.
Case Study: A detailed assessment of scaffold-free 3D cell culture products, featuring a list of more than 60 products that are being used for research and pharmaceutical testing, based on a number of relevant parameters, such as [A] status of development, [B] type of system, [C] type of product and [D] material used for fabrication.
Key Questions Answered in this Report
How many companies are currently engaged in this market?
Which are the leading companies in this market?
What factors are likely to influence the evolution of this market?
What is the current and future market size?
What is the CAGR of this market?
How is the current and future market opportunity likely to be distributed across key market segments?
What kind of partnership models are commonly adopted by industry stakeholders?
What is the ongoing investment trend in this market?
What is the patent filing activity trend in the market?
Reasons to Buy this Report
The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.
Additional Benefits
Complimentary PPT Insights Packs
Complimentary Excel Data Packs for all Analytical Modules in the Report
15% Free Content Customization
Detailed Report Walkthrough Session with Research Team
Free Updated report if the report is 6-12 months old or older
TABLE OF CONTENTS
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.2.1. Market Landscape and Market Trends
2.2.2. Market Forecast and Opportunity Analysis
2.2.3. Comparative Analysis
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Roots Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Types of Primary Research
2.4.2.1.1. Qualitative Research
2.4.2.1.2. Quantitative Research
2.4.2.1.3. Hybrid Approach
2.4.2.2. Advantages of Primary Research
2.4.2.3. Techniques for Primary Research
2.4.2.3.1. Interviews
2.4.2.3.2. Surveys
2.4.2.3.3. Focus Groups
2.4.2.3.4. Observational Research
2.4.2.3.5. Social Media Interactions
2.4.2.4. Key Opinion Leaders Considered in Primary Research
2.4.2.4.1. Company Executives (CXOs)
2.4.2.4.2. Board of Directors
2.4.2.4.3. Company Presidents and Vice Presidents
2.4.2.4.4. Research and Development Heads
2.4.2.4.5. Technical Experts
2.4.2.4.6. Subject Matter Experts
2.4.2.4.7. Scientists
2.4.2.4.8. Doctors and Other Healthcare Providers
2.4.2.5. Ethics and Integrity
2.4.2.5.1. Research Ethics
2.4.2.5.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Chapter Overview
3.2. Forecast Methodology
3.2.1. Top-down Approach
3.2.2. Bottom-up Approach
3.2.3. Hybrid Approach
3.3. Market Assessment Framework
3.3.1. Total Addressable Market (TAM)
3.3.2. Serviceable Addressable Market (SAM)
3.3.3. Serviceable Obtainable Market (SOM)
3.3.4. Currently Acquired Market (CAM)
3.4. Forecasting Tools and Techniques
3.4.1. Qualitative Forecasting
3.4.2. Correlation
3.4.3. Regression
3.4.4. Extrapolation
3.4.5. Convergence
3.4.6. Sensitivity Analysis
3.4.7. Scenario Planning
3.4.8. Data Visualization
3.4.9. Time Series Analysis
3.4.10. Forecast Error Analysis
3.5. Key Considerations
3.5.1. Demographics
3.5.2. Government Regulations
3.5.3. Reimbursement Scenarios
3.5.4. Market Access
3.5.5. Supply Chain
3.5.6. Industry Consolidation
3.5.7. Pandemic / Unforeseen Disruptions Impact
3.6. Key Market Segmentation
3.7. Robust Quality Control
3.8. Limitations
4. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Historical Evolution of Organ-on-chips
6.3. Design of Organ-on-chips
6.4. Classification of Organ-on-chips
6.4.1. Single Organ Chips
6.4.2. Disease / Therapeutic Specific Chips
6.4.3. Multi Organ Chips
6.5. Advantages and Limitations of Organ-on-chips
6.6. Applications of Organ-on-chips
6.7. Future Perspectives
7. MARKET LANDSCAPE: ORGAN-ON-CHIP TECHNOLOGIES AND MODELS
7.1. Chapter Overview
7.2. Organ-on-chip Technologies and Models Market: Overall Market Landscape
7.2.1. Analysis by Type of Model
7.2.2. Analysis by Compatible Organ
7.2.3. Analysis by Application Area
7.3. Organ-on-chip Technology and Models Market: Developer Landscape
7.3.1. Analysis by Year of Establishment
7.3.2. Analysis by Company Size
7.3.3. Analysis by Location of Headquarters
7.3.4. Analysis by Leading Technology Providers
8. MARKET LANDSCAPE: ORGAN-ON-CHIPS AND PLATES
8.1. Chapter Overview
8.2. Organ-on-Chips and Plates Market: Overall Market Landscape
8.2.1. Analysis by Type of Model
8.2.2. Analysis by Type of Product
8.2.3. Analysis by Compatible Organ
8.2.4. Analysis by Application Area
8.2.5. Analysis by Material of Construction
8.2.6. Analysis by Type of Polymer
8.2.7. Analysis by Status of Development
8.3. Organ-on-Chips and Plates Market: Developer Landscape
8.3.1. Analysis by Year of Establishment
8.3.2. Analysis by Company Size
8.3.3. Analysis by Location of Headquarters
8.3.4. Analysis by Leading Organ-on-Chips and Plates Providers
9. ORGAN-ON-CHIP PROVIDERS: COMPANY PROFILES OF PLAYERS BASED IN NORTH AMERICA
9.1. Chapter Overview
9.2. Emulate
9.2.1. Company Overview
9.2.2. Technology Portfolio
9.2.3. Product Portfolio
9.2.4. Recent Developments and Future Outlook
9.3. SynVivo
9.4. Draper
9.5. Hesperos
9.6. Xona Microfluidics
10. ORGAN-ON-CHIP PROVIDERS: COMPANY PROFILES OF PLAYERS BASED IN EUROPE
10.1. Chapter Overview
10.2. CN Bio
10.2.1. Company Overview
10.2.2. Technology Portfolio
10.2.3. Product Portfolio
10.2.4. Recent Developments and Future Outlook
10.3. Dynamic42
10.4. InSphero
10.5. Beonchip
10.6. BiomimX
10.7. Mimetas
10.8. NETRI
10.9. React4life
10.10. TissUse
11. ORGAN-ON-CHIP PROVIDERS: COMPANY PROFILES OF PLAYERS BASED IN ASIA-PACIFIC
11.1. Chapter Overview
11.2. Aim biotech
12. PATENT ANALYSIS
12.1. Chapter Overview
12.2. Scope and Methodology
12.3. Organ-on-Chip: Patent Analysis
12.3.1. Analysis by Type of Patent
12.3.2. Analysis by Patent Publication Year
12.3.3. Analysis by Patent Application Year
12.3.4. Analysis of Granted Patents by Publication Year
12.3.5. Analysis of Patent Applications by Publication Year
12.3.6. Analysis by Patent Jurisdiction
12.3.7. Analysis by CPC Symbols
12.3.8. Analysis by Type of Applicant
12.3.9. Analysis by Patent Age
12.3.10. Leading Inventors: Analysis by Number of Patents
12.3.11. Leading Industry Players: Analysis by Number of Patents
12.3.12. Leading Non-Industry Players: Analysis by Number of Patents
12.4. Patent Benchmarking Analysis
12.4.1. Analysis of Patent Characteristics (CPC Codes) by Leading Industry Players
12.5. Analysis by Patent Valuation
12.6. Leading Patents by Number of Citations
13. BRAND POSITIONING ANALYSIS: ORGAN-ON-CHIP TECHNOLOGIES AND MODELS PROVIDERS
13.1. Chapter Overview
13.2. Methodology
13.3. Key Parameters
13.4. Organ-on-Chip Technologies and Models Providers: Brand Positioning Framework
13.4.1. Brand Positioning Matrix: BiomimX
13.4.2. Brand Positioning Matrix: Hesperos
13.4.3. Brand Positioning Matrix: Emulate
13.4.4. Brand Positioning Matrix: Dynamic42
13.4.5. Brand Positioning Matrix: React4life
13.4.6. Brand Positioning Matrix: SynVivo
14. BRAND POSITIONING ANALYSIS: ORGAN-ON-CHIPS AND PLATES PROVIDERS
14.1. Chapter Overview
14.2. Methodology
14.3. Key Parameters
14.4. Organ-on-Chips and Plates Providers: Brand Positioning Framework
